Lorazepam: Clinical Trials

32 trials of Lorazepam, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 5 unknown, 3 recruiting, 3 terminated. 32 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 432Completed 17, Unknown 5, Recruiting 3, Terminated 3, Not yet recruiting 2, Suspended 1, Withdrawn 1

Follow Lorazepam: new trials by email Literature Review of Lorazepam trials Research Report on Lorazepam

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index
Lorazepam 1 mg, Placebo - Delirium Confusional State
Phase 4Not yet recruitingUniversity Hospital, Basel, Switzerland2602027-03-012026-02-27
HPV Vaccine Reduced Dose
Gardasil-9, Lidocaine injection, Lorazepam - HPV
Phase 4RecruitingEmory University1002025-08-062026-08-31
Computational Assessment of GABA Receptor Modulation in PTSD
Lorazepam 1 mg tablet, Placebo tablet - Stress Disorders, Post-Traumatic
Phase 4RecruitingVA Office of Research and Development1502025-07-012026-06-16
Ketamine for Sedation in Severe Traumatic Brain Injury
Ketamine with propofol, Standard of Care propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam - Severe Traumatic Brain Injury, Intracranial Hypertension
Phase 4SuspendedHenry M. Jackson Foundation for the Advancement of Military Medicine502024-09-232025-07-14
A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems
Mianserin, Lorazepam - Depression
Phase 4UnknownZhenghui YI3002024-07-012024-06-27
Efficacy of Hydroxyzine for Patients With Panic Disorder
Hydroxyzine, Escitalopram Oxalate - Panic Disorder
Phase 4Not yet recruitingSultan Qaboos University802023-12-302023-02-21
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
Lorazepam, Placebo - Depression, Anxiety, Fear
Phase 4RecruitingLaureate Institute for Brain Research, Inc.1652023-11-082025-10-31
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder
Phase 4UnknownTemple University322023-07-012023-10-23
Multimodal Analgesia Effect on Post Surgical Patient
Neurontin, Dilaudid Injectable Product, Marcaine Injectable Product - Obesity, Morbid, Surgery
Phase 4CompletedUniversity of California, Davis602021-01-202026-09-14
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
Phenobarbital, Lorazepam - Alcohol Withdrawal, Alcohol Withdrawal Delirium
Phase 4UnknownOSF Healthcare System1422020-07-062020-10-08
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
Placebo and fMRI, Lorazepam and fMRI - Schizophrenia, Bipolar Disorder
Phase 4CompletedUniversity of Michigan1432020-01-162026-06-17
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Ketamine, Phenobarbital, Lorazepam - Alcohol Withdrawal Syndrome
Phase 4WithdrawnSanta Barbara Cottage Hospital2019-04-122019-09-19
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
Haloperidol + lorazepam, Loxapine - Agitation,Psychomotor, Haloperidol Causing Adverse Effects in Therapeutic Use
Phase 4TerminatedUniversity of Arkansas22017-09-302018-06-11
Assessment of Valproate on Ethanol Withdrawal
Valproate, Lorazepam - Alcohol Dependence, Alcohol Withdrawal Syndrome
Phase 4TerminatedCAMC Health System32017-07-112026-08-18
Oral Sedation During Cervical Dilator Placement
Oxycodone and Lorazepam (Active Comparator), Placebo Comparator - Oral Sedation and Cervical Dilator Pain
Phase 4CompletedJohns Hopkins University272017-06-282020-03-30
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
Physostigmine, Lorazepam - Anticholinergics Toxicity
Phase 4CompletedUniversity of Colorado, Denver192017-03-302021-08-23
Gabapentin for Alcohol Withdrawal Syndrome
Gabapentin, Benzodiazepines, Divalproex Sodium - Alcohol Withdrawal Syndrome
Phase 4CompletedMayo Clinic882017-02-012022-03-24
A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise
Venlafaxine XR, Aerobic Exercise, Lorazepam - Depression, Depressive Disorder, Major
Phase 4CompletedKirk Erickson, PhD312015-03-012018-05-23
Therapeutic Hypothermia With Propofol in Survival and Neurological Prognoses After Cardiac Arrest
Propofol, Lorazepam - Hypothermia, Cardiac Arrest
Phase 4UnknownFar Eastern Memorial Hospital302013-08-012016-03-29
Characterizing and Predicting Drug Effects on Cognition
Lorazepam, Placebo, Topiramate 100mg - Cognitive Deficits
Phase 4CompletedUniversity of Minnesota602013-07-012019-12-17

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Anxiety Disorders (4)  ·  Depression (4)  ·  Alcoholism (3)  ·  Psychomotor Agitation (3)  ·  Bipolar Disorder (2)  ·  Generalized Anxiety Disorder (2)  ·  Psychotic Disorders (2)  ·  Schizophrenia (2)  ·  Agnosia (1)  ·  Alcohol Withdrawal Delirium (1)  ·  Brain Injuries, Traumatic (1)  ·  Cognition Disorders (1)  ·  Confusion (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Major (1)

Sponsors

Alexza Pharmaceuticals, Inc. (1)  ·  CAMC Health System (1)  ·  Elizabeth Micks (1)  ·  Emory University (1)  ·  Erasmus Medical Center (1)  ·  Far Eastern Memorial Hospital (1)  ·  GlaxoSmithKline (1)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (1)  ·  Hospital Universitari de Bellvitge (1)  ·  Johns Hopkins University (1)  ·  Kirk Erickson, PhD (1)  ·  Laureate Institute for Brain Research, Inc. (1)  ·  Mayo Clinic (1)  ·  Nathan Kline Institute for Psychiatric Research (1)  ·  National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1)

Countries

United States (22)  ·  Netherlands (2)  ·  Spain (2)  ·  Argentina (1)  ·  Austria (1)  ·  China (1)  ·  Costa Rica (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Finland (1)  ·  Greece (1)  ·  India (1)  ·  Indonesia (1)  ·  Lithuania (1)  ·  Mexico (1)

Top investigators

Audis Bethea, PharmD, BCPS (1)  ·  Barbara Jachniewicz, MSN, CRNFA, (1)  ·  Bhagat Aulakh, MD (1)  ·  Bradley Dengler, MD (1)  ·  Carolyn Sufrin (1)  ·  Elizabeth Micks, MD (1)  ·  Erin Scherer, PhD (1)  ·  George M Simpson, MD (1)  ·  George S Wang, MD (1)  ·  Jessica K Lee, MD (1)  ·  Jonathan R Howlett, MD (1)  ·  Kirk Erickson, PhD (1)  ·  Maria Ironside, DPhil (1)  ·  Markus Klimek, MD, PhD (1)

Results publications

PMID 16785215, PMID 21040558, PMID 23090523, PMID 23635914, PMID 24351233, PMID 27022468, PMID 27282374, PMID 30797651, PMID 32297992, PMID 37469099

NIH funding

K23AA000222 (1), K24AA016555 (1), R01MH059142 (1), R01MH118634 (1), R01MH132565 (1)